| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3905857 | Urology | 2006 | 5 Pages |
Abstract
Real-life clinical practice showed that long-term combination treatment with α-blockers and 5-alpha-reductase inhibitors reduced the risk of BPH progression, such as AUR or BPH-related surgery, compared with α-blocker-only treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Chun Il Kim, Hyuk Soo Chang, Byoung Kun Kim, Choal Hee Park,